Device Trial Radar · NCT06670651
LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
600
Planned (sponsor's estimate)
Start
Mar 21, 2025
Primary completion
Dec 2031
Study completion Dec 2031
Sponsor
- Lead sponsor
- LinkBio Corp.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 1, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.
Conditions
- Osteoarthritis (OA) of the Knee
- Fracture
- Rheumatoid Arthritis
Interventions
total knee arthroplasty deviceDevice
total knee arthroplasty device with ultracongruent bearing surface
Primary outcomes
What the sponsor says the trial is designed to measure.
- Knee Injury and Osteoarthritis Outcome Score - Joint Replacement (KOOS-JR) - change from baselineTime frame: 1 year postoperative
- Revision rateTime frame: 5 years postoperative
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
OrthoAlabama Spine & Sports
Birmingham, Alabama
Illinois Bone and Joint Institute
Libertyville, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.